N-Methylpiperidine

N-Methylpiperidine

SCHEMBL3452502

CN1CCCCC1.[Cl-].[H+]

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of N-Methylpiperidine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
N-Methylpiperidine SCHEMBL9042506 0.92 TDP1 (0.36)
SCHEMBL18807723 0.92 HRH3 (0.37)
SCHEMBL12952612 0.92 HRH3 (0.37)
SCHEMBL12316976 0.92 HRH3 (0.37)
SCHEMBL414741 0.92 HRH3 (0.37)
SCHEMBL20124473 0.92 HRH3 (0.37)
N-Methylpiperidine SCHEMBL6660565 0.92 HRH3 (0.37)
N-Methylpiperidine SCHEMBL1920 0.92
SCHEMBL21960469 0.92 HRH3 (0.37)
SCHEMBL3793955 0.92 HRH3 (0.37)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116284848-A Method for dissolving chitosan/cellulose by using multifunctional acidic ionic liquid 南京工业大学 2023-06-23 CN claimed
US-12398098-B2 Waterborne crosslinker composition COVESTRO (NETHERLANDS) B.V. (NL) 2025-08-26 US disclosed
CN-116284848-A Method for dissolving chitosan/cellulose by using multifunctional acidic ionic liquid 南京工业大学 2023-06-23 CN disclosed
US-20230193057-A1 WATERBORNE CROSSLINKER COMPOSITION COVESTRO (NETHERLANDS) B.V. (NL) 2023-06-22 US disclosed
EP-4093790-A1 WATERBORNE CROSSLINKER COMPOSITION Covestro (Netherlands) B.V. (NL) 2022-11-30 EP disclosed
CN-115038733-A Aqueous cross-linker composition 科思创(荷兰)有限公司 2022-09-09 CN disclosed
WO-2021148563-A1 WATERBORNE CROSSLINKER COMPOSITION COVESTRO (NETHERLANDS) B.V. (NL) 2021-07-29 WO disclosed
CN-106999973-A System and method for discharging edible material 阿甘芳香和精细化工有限公司 2017-08-01 CN disclosed
EP-1741697-B1 CRYSTAL COMPRISING (2R)-2-PROPYLOCTANOIC ACID AND DIBENZYLAMINE ONO PHARMACEUTICAL CO (JP) 2012-12-19 EP disclosed
US-8273916-B2 Crystal comprising (2R)-2-propyloctanoic acid and amine ONO PHARMACEUTICAL CO., LTD. (JP) 2012-09-25 US disclosed
US-20100331414-A1 CRYSTAL COMPRISING (2R)-2-PROPYLOCTANOIC ACID AND AMINE ONO PHARMACEUTICAL CO., LTD (JP) 2010-12-30 US disclosed
US-7820715-B2 Crystal comprising (2R)-2-propyloctanoic acid and amine ONO PHARMACEUTICAL CO., LTD. (JP) 2010-10-26 US disclosed
US-20080090907-A1 Crystal Comprising (2R)-2-Propyloctanoic Acid and Amine ONO PHARMACEUTICAL CO., LTD. (JP) 2008-04-17 US disclosed
EP-1741697-A1 CRYSTAL COMPRISING (2R)-2-PROPYLOCTOIC ACID AND AMINE ONO PHARMACEUTICAL CO., LTD. (JP) 2007-01-10 EP disclosed